Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study
A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes
High-throughput single-cell activity-based screening and sequencing of antibodies using droplet microfluidics
Antibody Discovery by Deep Mining of Immune Repertoires
Antibody Discovery by Deep Mining of Immune Repertoires: A demonstration of the HiFiBiO CelliGO™ Platform versatility and robustness with Tetanus Toxoid antigen as a case study. View Poster